The U.S. government announced funding cuts to mRNA vaccine research. What is the impact on American healthcare and biotech?

Fox News senior medical analyst Dr. Marc Siegel reflects on his interview with NIH Director Dr. Jay Bhattacharya addressing ...

Illinois researchers, including some working on vaccines for cancer and rare diseases, worry the federal government turning ...

They’re turning their backs on a technology thought to have saved millions of lives—with the potential to save many more.

NBC Medical Analyst and pulmonologist Dr. Vin Gupta reacts to HHS Secretary Robert F. Kennedy Jr.'s announcement to cut $500 ...

HHS reinstates vaccine safety task force apparently in response to looming lawsuit deadline by group Secretary Kennedy ...

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

HHS' decision "could stagnate research that has the potential to save millions of lives," writes Simon Williams.

The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be ...

The Department of Health and Human Services’ mRNA pullback only applies to their use in upper respiratory disease, according ...

HHS is slashing hundreds of millions in funding for mRNA vaccines and infectious disease treatments, but leaving the door ...

Director Jay Bhattacharya claims the federal government recently canceled millions of dollars’ worth of mRNA research ...